Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1 (Q59790609)

2

0 references

Timothy M Baran

3

0 references

Soumya Mitra

4

0 references

C Frank Bennett

5

0 references

Frank Rigo

6

0 references

Thomas H Foster

7

0 references

Thurman M Wheeler

Creative Commons Attribution 4.0 International

8

0 references

language of work or name

English

0 references

publication date

7 December 2018

0 references

published in

Nature Communications

0 references

volume

9

0 references

issue

1

0 references

page(s)

5227

0 references

copyright license

start time

1 December 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

A muscleblind knockout model for myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Splicing biomarkers of disease severity in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Targeting nuclear RNA for in vivo correction of myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

A bichromatic fluorescent reporter for cell-based screens of alternative splicing

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2 -ATPase in myotonic dystrophy type 1.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Assembly of the dystrophin-associated protein complex does not require the dystrophin COOH-terminal domain

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Functional consequences of developmentally regulated alternative splicing

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Alternative splicing dysregulation secondary to skeletal muscle regeneration

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Prevention of muscle aging by myofiber-associated satellite cell transplantation

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Analytical model for extracting intrinsic fluorescence in turbid media

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Factors influencing tumor response to photodynamic therapy sensitized by intratumor administration of methylene blue

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

In vivo mTHPC photobleaching in normal rat skin exhibits unique irradiance-dependent features

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

New Monte Carlo model of cylindrical diffusing fibers illustrates axially heterogeneous fluorescence detection: simulation and experimental validation

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Reducing levels of toxic RNA with small molecules

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Precise small-molecule recognition of a toxic CUG RNA repeat expansion.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

An engineered RNA binding protein with improved splicing regulation

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Impeding Transcription of Expanded Microsatellite Repeats by Deactivated Cas9.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Modulation of LMNA splicing as a strategy to treat prelamin A diseases.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Transgenic expression of green fluorescence protein can cause dilatedcardiomyopathy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

GFP expression in muscle cells impairs actin-myosin interactions: implications for cell therapy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Green fluorescent protein impairs actin-myosin interactions by binding to the actin-binding site of myosin

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Transduction of skeletal muscles with common reporter genes can promote muscle fiber degeneration and inflammation

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Dose-dependent Toxicity of Humanized Renilla reniformis GFP (hrGFP) Limits Its Utility as a Reporter Gene in Mouse Muscle

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Identification methods in newborn C57BL/6 mice: a developmental and behavioural evaluation.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Analysis of physiological and behavioural parameters in mice after toe clipping as newborns.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Enhancements and modifications of primer design program Primer3.

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Primer3--new capabilities and interfaces

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse

1 reference

https://api.crossref.org/works/10.1038/S41467-018-07517-Y

7 January 2021

Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30531949

12 December 2020